{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:47:50Z","timestamp":1792298870371,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T00:00:00Z","timestamp":1329955200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s11046-012-9529-8","type":"journal-article","created":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T18:19:42Z","timestamp":1329934782000},"page":"143-147","source":"Crossref","is-referenced-by-count":48,"title":["Molecular Identification and Antifungal Susceptibilities of Black Aspergillus Isolates from Otomycosis Cases in Hungary"],"prefix":"10.1007","volume":"174","author":[{"given":"Gy\u00f6ngyi","family":"Szigeti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"Kocsub\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"D\u00f3czi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Bereczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"V\u00e1gv\u00f6lgyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,23]]},"reference":[{"key":"9529_CR1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ijporl.2007.12.005","volume":"72","author":"R Munguia","year":"2008","unstructured":"Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008;72:453\u20139.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"9529_CR2","doi-asserted-by":"crossref","unstructured":"Bonifaz A, Chavolla-Magana R, Araiza J. Aspergillus otitis. In: Pasqualotto AC, editor. Aspergillosis: from diagnosis to prevention. Dordrecht: Springer; 2010. 7:999\u20131006.","DOI":"10.1007\/978-90-481-2408-4_58"},{"key":"9529_CR3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1439-0507.2007.01441.x","volume":"51","author":"J Fasunla","year":"2007","unstructured":"Fasunla J, Ibekwe T, Onakoya P. Otomycosis in western Nigeria. Mycoses. 2007;51:67\u201370.","journal-title":"Mycoses"},{"key":"9529_CR4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1258\/002221503321046621","volume":"117","author":"KM Ozcan","year":"2003","unstructured":"Ozcan KM, Ozcan M, Karaarslan A, Karaarslan F. Otomycosis in Turkey: predisposing factors, etiology and therapy. J Laryngol Otol. 2003;117:39\u201342.","journal-title":"J Laryngol Otol"},{"key":"9529_CR5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3114\/sim.2007.59.13","volume":"59","author":"RA Samson","year":"2007","unstructured":"Samson RA, Noonim P, Meijer M, Houbraken J, Frisvad JC, Varga J. Diagnostic tools to identify black aspergilli. Stud Mycol. 2007;59:129\u201345.","journal-title":"Stud Mycol"},{"key":"9529_CR6","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1128\/AAC.00585-09","volume":"53","author":"L Alcazar-Fuoli","year":"2009","unstructured":"Alcazar-Fuoli L, Mellado E, Aalastruey-Izquierdo A, Cuenca-Estrella M, Rodriguez-Tudela JL. Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri. Antimicrob Agents Chemother. 2009;53:4514\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"9529_CR7","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1128\/JCM.01070-09","volume":"47","author":"SA Balajee","year":"2009","unstructured":"Balajee SA, Kano R, Baddley JW, Moser SA, Marr KA, Alexander BD, Andes D, Kontoyiannis DP, Perrone G, Peterson S, Brandt ME, Pappas PG, Chiller T. Molecular identification of Aspergillus species: transplant associated infection surveillance network (TRANSNET). J Clin Microbiol. 2009;47:3138\u201341.","journal-title":"J Clin Microbiol"},{"key":"9529_CR8","unstructured":"Howard SJ, Harrison E, Bowyer P, Denning DW. Molecular identification of clinical black Aspergillus isolates and azole resistance. In: 3rd Advances Against Aspergillosis Conference, 16\u201318 January 2008, Miami, USA, 2008; 29 (Abstract Book). San Diego, CA: University of California San Diego School of Medicine."},{"key":"9529_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3114\/sim.2011.69.01","volume":"69","author":"J Varga","year":"2011","unstructured":"Varga J, Frisvad JC, Kocsub\u00e9 S, Brankovics B, T\u00f3th B, Szigeti G, Samson RA. New and revisited species in Aspergillus section Nigri. Stud Mycol. 2011;69:1\u201317.","journal-title":"Stud Mycol"},{"key":"9529_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3114\/sim.2007.59.05","volume":"59","author":"SA Balajee","year":"2007","unstructured":"Balajee SA, Houbraken J, Verweij PE, Hong SB, Yaghuchi T, Varga J, Samson RA. Aspergillus species identification in the clinical setting. Stud Mycol. 2007;59:39\u201346.","journal-title":"Stud Mycol"},{"key":"9529_CR11","doi-asserted-by":"crossref","unstructured":"Szigeti G, Sedaghati E, Zare R, Kocsub\u00e9 S, V\u00e1gv\u00f6lgyi C, Varga J. Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran. Mycoses. 2012. doi: 10.1111\/j.1439-0507.2011.02103.x .","DOI":"10.1111\/j.1439-0507.2011.02103.x"},{"key":"9529_CR12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.mycmed.2009.03.004","volume":"19","author":"E Aktas","year":"2009","unstructured":"Aktas E, Yigit N. Determination of antifungal susceptibility of Aspergillus spp. responsible for otomycosis by E-test method. J Mycol Med. 2009;19:122\u20135.","journal-title":"J Mycol Med"},{"key":"9529_CR13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1099\/ijs.0.63980-0","volume":"56","author":"SB Hong","year":"2006","unstructured":"Hong SB, Cho HS, Shin HD, Frisvad JC, Samson RA. Novel Neosartorya species isolated from soil in Korea. Int J Syst Evol Microbiol. 2006;56:477\u201386.","journal-title":"Int J Syst Evol Microbiol"},{"key":"9529_CR14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/sysbio\/42.2.182","volume":"42","author":"DM Hillis","year":"1993","unstructured":"Hillis DM, Bull JJ. An empirical test of bootstrapping as a method for assessing confidence in phylogenetic analysis. Syst Biol. 1993;42:182\u201392.","journal-title":"Syst Biol"},{"key":"9529_CR15","unstructured":"NCCLS. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard, Document M38-A. National Committee for Clinical Laboratory Standards, Wayne, PA; 2002."},{"key":"9529_CR16","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.funbio.2011.07.008","volume":"115","author":"G Perrone","year":"2011","unstructured":"Perrone G, Stea G, Epifani F, Varga J, Frisvad JC, Samson RA. Aspergillus niger contains the cryptic phylogenetic species A. awamori. Fungal Biol. 2011;115:1138\u201350.","journal-title":"Fungal Biol"},{"key":"9529_CR17","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1017\/S0022215109005489","volume":"123","author":"G Yenisehirli","year":"2009","unstructured":"Yenisehirli G, Bulut Y, G\u00fcven M, G\u00fcnday E. In vitro activities of fluconazole, itraconazole and voriconazole against otomycotic fungal pathogens. J Laryng Otal. 2009;123:978\u201381.","journal-title":"J Laryng Otal"},{"key":"9529_CR18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1439-0507.2004.00988.x","volume":"47","author":"A Karaarslan","year":"2004","unstructured":"Karaarslan A, Arikan S, Ozcan M, Ozcan KM. In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis. Mycoses. 2004;47:284\u20137.","journal-title":"Mycoses"},{"key":"9529_CR19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/jac\/41.5.567","volume":"41","author":"P Rath","year":"1998","unstructured":"Rath P. Susceptibility of Aspergillus strains from culture collections to amphotericin B and itraconazole. J Antimicrob Chemother. 1998;41:567\u201370.","journal-title":"J Antimicrob Chemother"},{"key":"9529_CR20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1439-0507.2007.01409.x","volume":"50","author":"A Kaya","year":"2007","unstructured":"Kaya A, Kiraz N. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole. Mycoses. 2007;50:447\u201350.","journal-title":"Mycoses"},{"key":"9529_CR21","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1111\/j.1439-0507.2010.01926.x","volume":"54","author":"R Pagiotti","year":"2011","unstructured":"Pagiotti R, Angelini P, Rubini A, Tirillini B, Granetti B. Venanzoni. Identification and characterisation of human pathogenic filamentous fungi and susceptibility to Thymus schimperi essential oil. Mycoses. 2011;54:e364\u201376.","journal-title":"Mycoses"},{"key":"9529_CR22","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1128\/AAC.45.6.1882-1885.2001","volume":"45","author":"CB Moore","year":"2001","unstructured":"Moore CB, Walls CM, Denning DW. In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B. Antimicrob Agents Chemother. 2001;45:1882\u201318855.","journal-title":"Antimicrob Agents Chemother"},{"key":"9529_CR23","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/AAC.32.5.780","volume":"32","author":"HJ Schmitt","year":"1988","unstructured":"Schmitt HJ, Bernard EM, Andrade J, Edwards F, Schmitt B, Armstrong D. MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp. Antimicrob Agents Chemother. 1988;32:780\u20131.","journal-title":"Antimicrob Agents Chemother"},{"key":"9529_CR24","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1128\/AAC.00304-11","volume":"55","author":"SJ Howard","year":"2011","unstructured":"Howard SJ, Harrison E, Bowyer P, Varga J, Denning DW. Cryptic species and azole resistance in the Aspergillus niger complex. Antimicrob Agents Chemother. 2011;55:4802\u20139.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-012-9529-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-012-9529-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-012-9529-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T06:34:57Z","timestamp":1713594897000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-012-9529-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,23]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["9529"],"URL":"https:\/\/doi.org\/10.1007\/s11046-012-9529-8","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,23]]}}}